144 related articles for article (PubMed ID: 38587752)
1. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON).
Appel KS; Nürnberger C; Bahmer T; Förster C; Polidori MC; Kohls M; Kraus T; Hettich-Damm N; Petersen J; Blaschke S; Bröhl I; Butzmann J; Dashti H; Deckert J; Dreher M; Fiedler K; Finke C; Geisler R; Hanses F; Hopff SM; Jensen BO; Konik M; Lehnert K; de Miranda SMN; Mitrov L; Miljukov O; Reese JP; Rohde G; Scherer M; Tausche K; Tebbe JJ; Vehreschild JJ; Voit F; Wagner P; Weigl M; Lemhöfer C;
Infection; 2024 Apr; ():. PubMed ID: 38587752
[TBL] [Abstract][Full Text] [Related]
2. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study.
Bahmer T; Borzikowsky C; Lieb W; Horn A; Krist L; Fricke J; Scheibenbogen C; Rabe KF; Maetzler W; Maetzler C; Laudien M; Frank D; Ballhausen S; Hermes A; Miljukov O; Haeusler KG; Mokhtari NEE; Witzenrath M; Vehreschild JJ; Krefting D; Pape D; Montellano FA; Kohls M; Morbach C; Störk S; Reese JP; Keil T; Heuschmann P; Krawczak M; Schreiber S;
EClinicalMedicine; 2022 Sep; 51():101549. PubMed ID: 35875815
[TBL] [Abstract][Full Text] [Related]
3. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP).
Hopff SM; Appel KS; Miljukov O; Schneider J; Addo MM; Bals R; Bercker S; Blaschke S; Bröhl I; Büchner N; Dashti H; Erber J; Friedrichs A; Geisler R; Göpel S; Hagen M; Hanses F; Jensen BO; Keul M; Krawczyk A; Lorenz-Depiereux B; Meybohm P; Milovanovic M; Mitrov L; Nürnberger C; Obst W; Römmele C; Schäfer C; Scheer C; Scherer M; Schmidt J; Seibel K; Sikdar S; Tebbe JJ; Tepasse PR; Thelen P; Vehreschild MJGT; Weismantel C; Vehreschild JJ
Infection; 2024 May; ():. PubMed ID: 38700656
[TBL] [Abstract][Full Text] [Related]
4. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
Schons M; Pilgram L; Reese JP; Stecher M; Anton G; Appel KS; Bahmer T; Bartschke A; Bellinghausen C; Bernemann I; Brechtel M; Brinkmann F; Brünn C; Dhillon C; Fiessler C; Geisler R; Hamelmann E; Hansch S; Hanses F; Hanß S; Herold S; Heyder R; Hofmann AL; Hopff SM; Horn A; Jakob C; Jiru-Hillmann S; Keil T; Khodamoradi Y; Kohls M; Kraus M; Krefting D; Kunze S; Kurth F; Lieb W; Lippert LJ; Lorbeer R; Lorenz-Depiereux B; Maetzler C; Miljukov O; Nauck M; Pape D; Püntmann V; Reinke L; Römmele C; Rudolph S; Sass J; Schäfer C; Schaller J; Schattschneider M; Scheer C; Scherer M; Schmidt S; Schmidt J; Seibel K; Stahl D; Steinbeis F; Störk S; Tauchert M; Tebbe JJ; Thibeault C; Toepfner N; Ungethüm K; Vadasz I; Valentin H; Wiedmann S; Zoller T; Nagel E; Krawczak M; von Kalle C; Illig T; Schreiber S; Witzenrath M; Heuschmann P; Vehreschild JJ;
Eur J Epidemiol; 2022 Aug; 37(8):849-870. PubMed ID: 35904671
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
Gentilotti E; Górska A; Tami A; Gusinow R; Mirandola M; Rodríguez Baño J; Palacios Baena ZR; Rossi E; Hasenauer J; Lopes-Rafegas I; Righi E; Caroccia N; Cataudella S; Pasquini Z; Osmo T; Del Piccolo L; Savoldi A; Kumar-Singh S; Mazzaferri F; Caponcello MG; de Boer G; Hara GL; ; De Nardo P; Malhotra S; Canziani LM; Ghosn J; Florence AM; Lafhej N; van der Gun BTF; Giannella M; Laouénan C; Tacconelli E
EClinicalMedicine; 2023 Aug; 62():102107. PubMed ID: 37654668
[TBL] [Abstract][Full Text] [Related]
6. Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients.
Román-Montes CM; Flores-Soto Y; Guaracha-Basañez GA; Tamez-Torres KM; Sifuentes-Osornio J; González-Lara MF; de León AP
Front Public Health; 2023; 11():1155951. PubMed ID: 37255755
[TBL] [Abstract][Full Text] [Related]
7. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Horn A; Krist L; Lieb W; Montellano FA; Kohls M; Haas K; Gelbrich G; Bolay-Gehrig SJ; Morbach C; Reese JP; Störk S; Fricke J; Zoller T; Schmidt S; Triller P; Kretzler L; Rönnefarth M; Von Kalle C; Willich SN; Kurth F; Steinbeis F; Witzenrath M; Bahmer T; Hermes A; Krawczak M; Reinke L; Maetzler C; Franzenburg J; Enderle J; Flinspach A; Vehreschild J; Schons M; Illig T; Anton G; Ungethüm K; Finkenberg BC; Gehrig MT; Savaskan N; Heuschmann PU; Keil T; Schreiber S
Infection; 2021 Dec; 49(6):1277-1287. PubMed ID: 34642875
[TBL] [Abstract][Full Text] [Related]
8. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation.
Kuchler T; Günthner R; Ribeiro A; Hausinger R; Streese L; Wöhnl A; Kesseler V; Negele J; Assali T; Carbajo-Lozoya J; Lech M; Schneider H; Adorjan K; Stubbe HC; Hanssen H; Kotilar K; Haller B; Heemann U; Schmaderer C
Angiogenesis; 2023 Nov; 26(4):547-563. PubMed ID: 37507580
[TBL] [Abstract][Full Text] [Related]
9. Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
Steinbeis F; Thibeault C; Steinbrecher S; Ahlgrimm Y; Haack IA; August D; Balzuweit B; Bellinghausen C; Berger S; Chaplinskaya-Sobol I; Cornely O; Doeblin P; Endres M; Fink C; Finke C; Frank S; Hanß S; Hartung T; Hellmuth JC; Herold S; Heuschmann P; Heyckendorf J; Heyder R; Hippenstiel S; Hoffmann W; Kelle SU; Knape P; Koehler P; Kretzler L; Leistner DM; Lienau J; Lorbeer R; Lorenz-Depiereux B; Lüttke CD; Mai K; Merle U; Meyer-Arndt LA; Miljukov O; Muenchhoff M; Müller-Plathe M; Neuhann J; Neuhauser H; Nieters A; Otte C; Pape D; Pinto RM; Pley C; Pudszuhn A; Reuken P; Rieg S; Ritter P; Rohde G; Rönnefarth M; Ruzicka M; Schaller J; Schmidt A; Schmidt S; Schwachmeyer V; Schwanitz G; Seeger W; Stahl D; Stobäus N; Stubbe HC; Suttorp N; Temmesfeld B; Thun S; Triller P; Trinkmann F; Vadasz I; Valentin H; Vehreschild M; von Kalle C; von Lilienfeld-Toal M; Weber J; Welte T; Wildberg C; Wizimirski R; Zvork S; Sander LE; Vehreschild J; Zoller T; Kurth F; Witzenrath M
Infection; 2024 Feb; 52(1):93-104. PubMed ID: 37434025
[TBL] [Abstract][Full Text] [Related]
10. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
11. 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.
Augustin M; Stecher M; Wüstenberg H; Di Cristanziano V; Sandaradura de Silva U; Picard LK; Pracht E; Rauschning D; Gruell H; Klein F; Wenisch C; Hallek M; Schommers P; Lehmann C
Front Immunol; 2023; 14():1226622. PubMed ID: 37781408
[TBL] [Abstract][Full Text] [Related]
12. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
[TBL] [Abstract][Full Text] [Related]
14. Post-COVID-19 syndrome symptoms after mild and moderate SARS-CoV-2 infection.
Al-Husinat L; Nusir M; Al-Gharaibeh H; Alomari AA; Smadi MM; Battaglini D; Pelosi P
Front Med (Lausanne); 2022; 9():1017257. PubMed ID: 36262270
[TBL] [Abstract][Full Text] [Related]
15. Variations and Predictors of Post-COVID Syndrome Severity in Patients Attending a Post-COVID Outpatient Clinic.
Lemhöfer C; Bahmer T; Baumbach P; Besteher B; Boekel A; Finke K; Katzer K; Lehmann-Pohl K; Lewejohann JC; Loudovici-Krug D; Nowka M; Puta C; Quickert S; Reuken PA; Walter M; Stallmach A
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373706
[TBL] [Abstract][Full Text] [Related]
16. Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19.
Malesevic S; Sievi NA; Baumgartner P; Roser K; Sommer G; Schmidt D; Vallelian F; Jelcic I; Clarenbach CF; Kohler M
Sci Rep; 2023 May; 13(1):7717. PubMed ID: 37173355
[TBL] [Abstract][Full Text] [Related]
17. Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
Legler F; Meyer-Arndt L; Mödl L; Kedor C; Freitag H; Stein E; Hoppmann U; Rust R; Wittke K; Siebert N; Behrens J; Thiel A; Konietschke F; Paul F; Scheibenbogen C; Bellmann-Strobl J
EClinicalMedicine; 2023 Sep; 63():102146. PubMed ID: 37662515
[TBL] [Abstract][Full Text] [Related]
18. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study.
Walker S; Goodfellow H; Pookarnjanamorakot P; Murray E; Bindman J; Blandford A; Bradbury K; Cooper B; Hamilton FL; Hurst JR; Hylton H; Linke S; Pfeffer P; Ricketts W; Robson C; Stevenson FA; Sunkersing D; Wang J; Gomes M; Henley W; Collaboration LWCR
BMJ Open; 2023 Jun; 13(6):e069217. PubMed ID: 37286327
[TBL] [Abstract][Full Text] [Related]
19. Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN).
Haberland E; Haberland J; Richter S; Schmid M; Hromek J; Zimmermann H; Geng S; Winterer H; Schneider S; Kollum M
Int J Clin Pract; 2022; 2022():8373697. PubMed ID: 36035510
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with the quality of life and persistent dyspnea severity in COVID-19 survivors: A cross-sectional study among healthcare workers.
Sinaga JP; Sinaga BY; Siagian P; Eyanoer PC; Unata IM
Narra J; 2023 Dec; 3(3):e419. PubMed ID: 38455626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
